Mortality profile of myeloid and lymphoid leukemias in Brazil: 2000 to 2018 / Perfil de mortalidade por leucemias mieloide e linfoide no Brasil: 2000 a 2018

Authors

  • Mônica Christine Alves Cabral Cardoso
  • Regiane Cristina do Amaral
  • Shirlei Octacílio da Silva

DOI:

https://doi.org/10.34117/bjdv8n3-414

Keywords:

leukemia, lymphoid, myeloid, mortality.

Abstract

Introduction: Leukemias, despite their declining mortality over the years, continue to be a major public health problem in Brazil. Objective: to analyze trends in mortality from myeloid leukemia (LM) and lymphoid leukemia (LL) in Brazil from 2000 to 2018, correlating with health services and municipal human development index (MHDI). Methods: Data were collected from DATASUS databases for the year 2000 to 2018, regarding mortality rate, number of specialized hospitals, MDHI, primary care coverage and population by state. Correlation analyzes were performed between the studied variables and time series analysis to measure trends over the years (VPA – annual percentage change). Results: Approximately 50% of the Brazilian states showed a tendency to increase mortality from LL and LM. The North and Northeast regions have higher APC and lower MDHI. There is a statistically significant difference between MHDI and referral hospitals (p = 0.000; r = 0.64) and MHDI with primary care (p = 0.034; r = -0.41). For LL, mortality is higher in men (p < 0.001). There was a statistically significant correlation for LL mortality rate in women with primary care coverage (p=0.049; r=-0.38). Conclusions: Approximately 50% of Brazilian states showed increasing mortality. Mortality is higher in men with LL. Mortality of women with LL is lower where there are more primary and referral centers.

References

Instituto Nacional de Câncer (INCA). Estimativa 2020: Incidência de câncer no Brasil [Internet]. Rio de Janeiro, 2019. http://www.inca.gov.br/estimativa/2020/estimativa- 2020-v11.pdf. [accessed 2020 Nov 28].

Juliusson G, Hough R. Leukemia. Prog Tumor Res. 2016;43: 87-100.

Crossnohere, N L; Richardson, D R; Reinhart, C; O’Donoghue, B; Love, S M; Douglas, B. Side effects from acute myeloid leukemia treatment: results from a national survey. Curr Med Res Opin. 2019 Nov;35(11):1965-1970.

Naffah Filho M, Cecilio MAM. Subsídios para um novo modelo de atenção ao câncer no Estado de São Paulo. Rev Adm Saúde. São Paulo. 2005; v. 7, n. 28.

Teixeira LA, Porto M, Habib PABB. Políticas públicas de controle de câncer no Brasil: elementos de uma trajetória. Cad. Saúde Colet., 2012, Rio de Janeiro, 20 (3): 375-80.

Jorge MHPM, Gotlieb SLD, Laurenti R. O sistema de informações sobre mortalidade: problemas e propostas para o seu enfrentamento I - Mortes por causas naturais. Rev. bras. epidemiol. 2002 Aug; 5 (2): 197-211.

Cestari MEW, Zago MMF. A prevenção do câncer e a promoção de saúde: um desafio para o Século XXI. Rev Bras Enferm. 2005 mar-abr; 58(2):218-21.

Parada, R; de Assis, M da Silva, R.C.F; Maria Fátima Abreu; da Silva, M.A.F; Dias, M.B. K; Tomazell. J.G. A política nacional de atenção oncológica e o papel da atenção básica na prevenção e controle do câncer. Phys Rev E, v. 11, n. 2, p. 199-206, abr./jun. 2008.

Silva M, Lima F, O’Dwyer G, Osorio-de-Castro C. Política de Atenção ao Câncer no Brasil após a Criação do Sistema Único de Saúde. RSBC. 2017 Abr/Jun 63 (3). 177-187.

Crossnohere, N L; Richardson, D R; Reinhart, C; O’Donoghue, B; Love, S M; Douglas, B. Side effects from acute myeloid leukemia treatment: results from a national survey. Curr Med Res Opin. 2019 Nov;35(11):1965-1970.

Instituto Brasileiro de Geografia e Estatística (IBGE) [Internet]. Brasília, 2020. Available in: https://www.ibge.gov.br/apps//populacao/projecao/. [accessed 2020 October 20].

E-Gestor. Atenção Básica. Available in: https://egestorab.saude.gov.br/.[accessed 2020 October 20].

Antunes JLF, Waldman EA. Tuberculosis in the twentieth century: time-series mortality in São Paulo, Brazil, 1900-97. Cadernos de Saúde Pública. 1999; 15(3): 463-476.

Bertuccio P, Bosetti C, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012. Int J Cancer. 2013 Jan;132(2):427-36.

Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, et al. European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 2016;27(4):725-31.

Dias, PP; Silva, ADS; Oliveira, JSA. Mortalidade infantil por leucemia linfoide nas regiões do Brasil. R-BITS. 2016; v. 6, n. 1.

Ferman S, Santos MdO, Ferreira JMdO, Reis RdS, Oliveira JFP, Pombo-de-Oliveira MS, et al. Childhood cancer mortality trends in Brazil, 1979-2008. Clinics. 2013; 68:219-24.

Howard SC,Pedrosa M,Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource‐poor area. JAMA. 2004; 291: 2471–2475.

Ribeiro RC,Pui CH. Saving the children: improving childhood cancer treatment in developing countries. N Engl J Med. 2005; 352: 2158–2160.

Cai J, Yu J, Zhu X, Hu S, Zhu Y, Jiang H, Li C, Fang Y, Liang C, Ju X, Tian X, Zhai X, Hao J, Hu Q, Wang N, Jiang H, Sun L, Li CK, Pan K, Yang M, Shen S, Cheng C, Ribeiro RC, Pui CH, Tang J; Chinese Children’s Cancer Group childhood acute lymphoblastic leukaemia (ALL) 2015 study group (CCCG-ALL-2015). Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children's Cancer Group. Arch Dis Child. 2019 Jun;104(6):522-529.

Jabeen K, Ashraf MS, Iftikhar S, Belgaumi AF. The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC). J Pediatr Hematol Oncol. 2016 Nov;38(8):587-596.

Viana, SS; JMMR; Nascimento, JB; Cardoso, CAF; Rosário, ACD; Mendonça, CQ; Menezes-Neto, OA; Cipolotti, R. Secular trends and predictors of mortality in acute lymphoblastic leukemia for children of low socioeconomic level in Northeast Brazil. Leuk Res. 2015; 10 (39):1060-1065.

Ribeiro KB, Lopes LF, Camargo B. Trends in childhood leukemia mortality in Brazil and correlation with social inequalities. Cancer. 2007 Oct;110(8):1823–31.

Silva DS, Mattos IE, Teixeira LR. Tendência de mortalidade por leucemias e linfomas em menores de 20 anos, Brasil. Revista Brasileira de Cancerologia. 2013; 59 (2):165-73.

Silva FF, Zandonade E, Zouain-Figueiredo GP. Analysis of childhood leucemia mortality trends in Brazil, from1980 to 2010. J Pediatr (RioJ). 2014; 90:587-92.

Silva-Junior AL, Alves FS, Kerr MWA, Xabregas LA, Gama FM, Rodrigues MGA, Torres AS, Tarragô AM, Sampaio VS, Carvalho MPSS, Fraiji NA, Malheiro A, Costa AG. Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths. PLoS One. 2019 Aug 22;14(8):e0221518.

Haraki CAC, Gotlieb SLD, Laurenti R. Confiabilidade do Sistema de Informações sobre Mortalidade em município do sul do Estado de São Paulo. Rev. bras. epidemiol. [Internet]. 2005 Mar [accessed 2021 Jan 12]; 8(1): 19-24.

Queiroz RCS, Mattos IE, Monteiro GTR, Koifman S. Confiabilidade e validade das declarações de óbito por câncer de boca no Município do Rio de Janeiro. Cad Saúde Pública [Internet]. 2003 Dec [accessed 2021 Jan 12]; 19(6): 1645-1653.

Published

2022-03-30

How to Cite

Cardoso, M. C. A. C., do Amaral, R. C., & da Silva, S. O. (2022). Mortality profile of myeloid and lymphoid leukemias in Brazil: 2000 to 2018 / Perfil de mortalidade por leucemias mieloide e linfoide no Brasil: 2000 a 2018. Brazilian Journal of Development, 8(3), 22033–22044. https://doi.org/10.34117/bjdv8n3-414

Issue

Section

Original Papers